PRESCIENT THERAPEUTICS LTD

Prescient Therapeutics Slides in Bullish Market: Low Liquidity, Narrow Support, & Rising Investor Caution

Prescient Therapeutics drops 1.75% to A$0.05 – a risky biotech whose low liquidity and stagnant valuation warn investors of a tough road ahead.

PRESCIENT THERAPEUTICS LTD
Australia
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Vanessa Liu

23/10/2026, 23:59

3 minutes to read

Prescient Therapeutics Stock Falls 16%: Latest ASX Performance & 200‑Day Trend

Prescient Therapeutics drops 1.7% to AU$0.06, after a 16% monthly decline. Learn its market cap, 52‑week highs, and biotech focus on myeloma, breast & pancreatic cancer.

PRESCIENT THERAPEUTICS LTD
Australia
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Elliot Mercer

22/10/2026, 07:13

One minute to read